<DOC>
	<DOCNO>NCT00685152</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled study evaluate efficacy safety high-frequency ( 20Hz ) rTMS apply right dorsolateral prefrontal cortex 6 week . The primary objective evaluate change PTSD symptom six week high-frequency rTMS treatment measure Clinician Administered PTSD Scale ( CAPS ) active control group .</brief_summary>
	<brief_title>High Frequency Repetitive Transcranial Magnetic Stimulation ( rTMS ) Treatment Post-traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>Signed Patient Information Consent . Patients primary PostTraumatic Stress Disorder ( diagnose MINI ) DSM IV TR . Patients CAPS score least 40 . Males females 1865 year age . Patients take PTSD pharmacotherapy least last 2 week prior commence study take PTSD pharmacotherapy must stable least 6 week prior start change 6 week study treatment phase . Individual group supportive psychotherapy may continue study allow start new psychotherapy 6 week study treatment phase . Current primary Axis I disorder include Schizophrenia , Bipolar Disorder type I , Major Depressive Disorder . Other primary Axis I disorder , opinion investigator , may affect outcome study . Patients HDRS score ≥ 18 . A metallic implant cranium ( except mouth ) . Patients severe unstable medical condition , opinion investigator would interfere progress safety . ECT treatment within last three month . Patients history epilepsy . Patients neurological disorder lead increase intracranial pressure . Patients severe cardiac disorder intracardiac line pacemaker . Patients current suicide risk ≥ 6 point MINI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>